|
KMID : 1240020220260000106
|
|
International Neurourology Journal
2022 Volume.26 No. 0 p.106 ~ p.116
|
|
|
Striatal ZBTB16 Is Associated With Cognitive Deficits in Alzheimer Disease Mice
|
|
Lee Sang-Joon
Kim Tae-Kyoo
Choi Ji-Eun
Kim Hye-Sun
Im Heh-In
|
|
|
Abstract
|
|
|
Purpose: In Alzheimer disease (AD), brain regions such as the cortex and the hippocampus show abundant amyloid load which correlates with cognitive function decline. Prior to the significant development of AD pathophysiology, patients report the manifestation of neuropsychiatric symptoms, indicating a functional interplay between basal ganglia structures and hippocampal regions. Zinc finger and BTB domain-containing protein 16 (ZBTB16) is a transcription factor that controls the expression of downstream genes and the involvement of ZBTB16 in the striatum undergoing pathological aging in AD and the resulting behavioral phenotypes has not yet been explored.
Methods: To study molecular alterations in AD pathogenesis, we analyzed the brain from amyloid precursor protein (APP)/ presenilin 1 (PS1) transgenic mice. The molecular changes in the striatal region of the brain were analyzed via the immunoblotting, and the quantitative RNA sequencing. The cognitive impairments of APP/PS1 mice were assessed via 3 behavioral tests: 3-chamber test, Y-maze test, and noble object recognition test. And multielectrode array experiments for the analysis of the neuronal activity of the striatum in APP/PS1 mice was performed.
Results: We found that the alteration in ZBTB16 levels that occurred in the early ages of the pathologically aging striatum coalesces with the disruption of transcriptional dysregulation while causing social memory deficits, anxiety-like behavior. The early ZBTB16 knockdown treatment in the striatum of APP/PS1 mice rescued cognition that continued into later age.
Conclusion: This study demonstrates that perturbation of transcriptional regulation of ZBTB16 during pathological aging may influence cognitive impairments and reveals a potent approach to targeting the transcriptional regulation of the striatum for the treatment of AD.
|
|
|
KEYWORD
|
|
|
Alzheimer disease, Cognitive dysfunctions, Striatum, Transcription factors, ZBTB16.
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|